By Counterforce Health Team in Symdeko / Symkevi (tezacaftor/ivacaftor) —

Getting Symdeko (Tezacaftor/Ivacaftor) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization Guide

Answer Box: Your Path to Symdeko Coverage in Virginia

Symdeko (tezacaftor/ivacaftor) requires prior authorization from UnitedHealthcare, with specific genotype documentation and specialist requirements. The fastest path: 1) Confirm F508del mutation status via FDA-cleared testing, 2) Have your CF specialist submit UnitedHealthcare's Symdeko Prior Authorization form with complete clinical documentation, 3) If denied, file internal appeal within 180 days, then Virginia external review within 120 days through the State Corporation Commission Bureau of Insurance. Start today: Contact your CF care team to gather genotype results and clinical notes.

Table of Contents

  1. Coding Basics: Medical vs. Pharmacy Benefit Paths
  2. ICD-10 Mapping for Cystic Fibrosis
  3. Product Coding: HCPCS, NDC, and Units
  4. Clean Request Anatomy: PA Documentation
  5. Frequent Coding Pitfalls
  6. Verification with UnitedHealthcare Resources
  7. Pre-Submission Audit Checklist
  8. Appeals Playbook for Virginia
  9. Cost-Saving Options
  10. FAQ

Coding Basics: Medical vs. Pharmacy Benefit Paths

Symdeko (tezacaftor/ivacaftor) is an oral specialty medication that typically falls under your pharmacy benefit, not the medical benefit used for provider-administered drugs. This distinction affects how the medication is coded and billed.

Pharmacy Benefit Path (Most Common):

  • Dispensed for home use by specialty pharmacy
  • Billed using NDC (National Drug Code)
  • Requires pharmacy prior authorization through OptumRx
  • Patient picks up or receives home delivery

Medical Benefit Path (Rare):

  • Only if administered in a clinical setting
  • Uses HCPCS code J8499 ("Prescription drug, oral, non-chemotherapeutic, Not Otherwise Specified")
  • Requires medical prior authorization
Note: Most UnitedHealthcare plans process Symdeko through the pharmacy benefit. Confirm your specific coverage by calling the member services number on your insurance card.

ICD-10 Mapping for Cystic Fibrosis

Accurate ICD-10 coding is essential for establishing medical necessity. Your healthcare provider will use these codes based on your specific CF manifestations:

ICD-10 Code Description When to Use
E84.0 Cystic fibrosis with pulmonary manifestations Most common; includes lung involvement
E84.11 Cystic fibrosis with meconium ileus History of meconium ileus
E84.19 Cystic fibrosis with other intestinal manifestations Pancreatic insufficiency, DIOS
E84.8 Cystic fibrosis with other manifestations CF-related diabetes, liver disease
E84.9 Cystic fibrosis, unspecified When specific manifestations aren't documented

Documentation Words That Support Coding:

  • "Chronic productive cough"
  • "Pancreatic insufficiency"
  • "CF-related complications"
  • "Progressive pulmonary disease"
  • "Recurrent respiratory infections"

Your CF specialist will select the most appropriate code based on your clinical presentation and documented complications.

Product Coding: HCPCS, NDC, and Units

NDC Codes for Symdeko

When billing through pharmacy benefit, use the specific NDC matching your dispensed product:

  • Standard packaging NDC: Verify current NDC with your specialty pharmacy
  • Units: Bill per tablet dispensed
  • Typical quantity: 168 tablets per 84 days (56 tablets monthly)

HCPCS Code (Medical Benefit Only)

If billed under medical benefit: J8499 - "Prescription drug, oral, non-chemotherapeutic, Not Otherwise Specified"

Units Calculation

Standard Dosing:

  • Morning: One tezacaftor 100mg/ivacaftor 150mg tablet
  • Evening: One ivacaftor 150mg tablet
  • Daily total: 2 tablets
  • Monthly supply: 56 tablets (28 days)
  • Quarterly supply: 168 tablets (84 days)
Tip: UnitedHealthcare typically approves 84-day supplies for specialty medications. Confirm quantity limits with your plan.

Clean Request Anatomy: PA Documentation

A complete Symdeko prior authorization includes these essential components:

Required Clinical Documentation

  1. Cystic Fibrosis Diagnosis
    • ICD-10 code (E84.x series)
    • Date of diagnosis
    • Confirming diagnostic tests (sweat chloride, genetic testing)
  2. Genotype Documentation
    • Laboratory report showing F508del mutation status
    • Homozygous F508del OR heterozygous with responsive mutation
    • FDA-cleared CF mutation panel results
  3. Age Verification
    • Patient must be ≥6 years old
    • Date of birth documentation
  4. Prescriber Information
    • CF specialist or pulmonologist preferred
    • Provider NPI and contact information
    • Specialty certification
  5. Treatment History
    • Previous CFTR modulators tried
    • Outcomes and reasons for discontinuation
    • Current CF therapies

Medical Necessity Letter Components

Your CF specialist should include:

  • Clinical rationale: Why Symdeko is appropriate for your specific genotype
  • Treatment goals: Expected improvements in lung function, symptoms
  • Monitoring plan: Safety assessments and efficacy measures
  • Literature support: References to clinical trials and guidelines

Frequent Coding Pitfalls

Common Mistakes That Delay Approval

1. Genotype Documentation Errors

  • ❌ Incomplete mutation testing
  • ✅ Full FDA-cleared CF panel with F508del status clearly stated

2. Age Requirement Oversights

  • ❌ Missing date of birth verification
  • ✅ Clear documentation of age ≥6 years

3. Prescriber Specialty Issues

  • ❌ Primary care provider without CF expertise
  • ✅ CF specialist or pulmonologist with documented credentials

4. Quantity Limit Mismatches

  • ❌ Requesting 90-day supply when plan allows 84 days
  • ✅ Align quantity with plan-specific limits

5. Missing Treatment History

  • ❌ No documentation of previous therapies
  • ✅ Complete history of CFTR modulators and outcomes

Verification with UnitedHealthcare Resources

Before submitting your prior authorization, verify requirements through these official channels:

Provider Resources

  • UnitedHealthcare Provider Portal: Check current PA requirements and forms
  • Symdeko Prior Authorization Form: Download from UHC Provider site
  • OptumRx Formulary: Verify current tier status and quantity limits

Member Resources

  • Member Services: Call number on insurance card
  • Online Member Portal: Check coverage details and PA status
  • Explanation of Benefits (EOB): Review for coverage determinations

Cross-Check Steps

  1. Confirm Symdeko is on your plan's formulary
  2. Verify current quantity limits (typically 168 tablets/84 days)
  3. Check if step therapy requirements apply
  4. Confirm prescriber network status

Pre-Submission Audit Checklist

Use this checklist before submitting your Symdeko prior authorization:

Patient Information ✓

  • Complete demographics and insurance information
  • Date of birth confirming age ≥6 years
  • Member ID and group number accurate

Clinical Documentation ✓

  • CF diagnosis with appropriate ICD-10 code
  • Genotype report showing F508del mutation status
  • Laboratory results from FDA-cleared testing
  • Current CF treatment regimen documented

Prescriber Requirements ✓

  • CF specialist or pulmonologist
  • Provider NPI and contact information
  • Medical necessity letter included
  • Treatment history and rationale provided

Administrative Details ✓

  • Correct NDC code for dispensed product
  • Quantity aligns with plan limits
  • Pharmacy information complete
  • All required forms signed and dated

Appeals Playbook for Virginia

If your Symdeko prior authorization is denied, Virginia provides a structured appeals process with specific timelines and protections.

Internal Appeals (UnitedHealthcare)

Level 1: Standard Internal Appeal

  • Deadline: File within 180 days of denial notice
  • Timeline: Decision within 30 days (standard) or 72 hours (expedited)
  • How to file: UnitedHealthcare provider portal, phone, fax, or mail
  • Required documents: Denial letter, additional clinical evidence, prescriber letter

Level 2: Second Internal Review

  • May be available depending on plan type
  • Same timeline and submission methods

External Review (Virginia Bureau of Insurance)

Eligibility Requirements:

  • Must exhaust all UnitedHealthcare internal appeals
  • Denial based on medical necessity or experimental treatment
  • Virginia-issued plan or opted-in self-funded plan

Process Steps:

  1. File within 120 days of final internal denial
  2. Complete Form 216-A: External Review Request
  3. Submit to Virginia State Corporation Commission Bureau of Insurance
  4. Include all supporting documentation

Timeline:

  • Standard review: 45 days
  • Expedited review: 72 hours (if medically urgent)

Contact Information:

  • Consumer Services: 1-877-310-6560
  • Managed Care Ombudsman: Available for guidance and assistance
Virginia Advantage: The state allows expedited external review for certain urgent cases without completing all internal appeals first.

Required Documentation for Appeals

  • Original denial letter from UnitedHealthcare
  • Updated medical records and clinical notes
  • Additional supporting literature
  • Prescriber letter addressing denial reasons
  • Completed appeal forms

Cost-Saving Options

Symdeko's annual list price approaches $323,491, making financial assistance crucial for many patients.

Manufacturer Support Programs

Vertex Patient Services

  • Copay assistance for eligible commercial insurance
  • Patient assistance program for uninsured/underinsured
  • Case management and prior authorization support
  • Contact: Vertex Patient Services program

Foundation Grants

  • Cystic Fibrosis Foundation: Compass program for CF-related expenses
  • HealthWell Foundation: Grants for specialty medication copays
  • Patient Advocate Foundation: Co-Pay Relief program

State-Specific Resources

Virginia Programs:

  • Virginia Medicaid (expanded 2019) covers eligible adults
  • State pharmaceutical assistance programs
  • Hospital charity care programs

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeals processes for medications like Symdeko.

FAQ

How long does UnitedHealthcare prior authorization take for Symdeko in Virginia? Standard PA decisions are typically made within 24-72 hours once complete documentation is received. Expedited requests for urgent medical needs may be decided within 24 hours.

What if Symdeko is non-formulary on my UnitedHealthcare plan? Non-formulary medications require additional documentation and may have higher cost-sharing. Your provider can request a formulary exception with strong clinical justification for why Symdeko is medically necessary over formulary alternatives.

Can I request an expedited appeal if my Symdeko is denied? Yes, if your CF specialist certifies that waiting for standard review could seriously jeopardize your health. Expedited internal appeals are decided within 72 hours, and Virginia's expedited external review is available within 72 hours for urgent cases.

Does step therapy apply to Symdeko with UnitedHealthcare? UnitedHealthcare may require trying other CFTR modulators first, depending on your specific plan. However, exceptions are available when alternatives are contraindicated or have failed. Your CF specialist can provide clinical justification for step therapy exceptions.

What happens if I move from Virginia to another state during treatment? Your UnitedHealthcare coverage typically remains the same, but external review rights will be governed by your new state's regulations. Contact UnitedHealthcare member services to confirm continued coverage and any required updates.

How do I know if my CF genotype qualifies for Symdeko coverage? Symdeko is approved for patients with homozygous F508del mutations or at least one F508del mutation plus another responsive mutation. Your CF care team can review your genetic testing results and confirm eligibility based on FDA-approved indications.

Can my primary care doctor prescribe Symdeko, or do I need a specialist? While technically possible, UnitedHealthcare strongly prefers prescriptions from CF specialists or pulmonologists. Specialist prescribing significantly improves approval likelihood and demonstrates appropriate clinical oversight.

What should I do if UnitedHealthcare doesn't respond to my prior authorization within the stated timeline? Contact UnitedHealthcare member services immediately to check status. If delays persist, you can file a complaint with Virginia's Bureau of Insurance at 1-877-310-6560 for assistance in ensuring timely processing.

Sources & Further Reading

For additional support with complex prior authorizations and appeals, Counterforce Health provides specialized assistance in analyzing denial letters and creating evidence-backed appeals that align with payer-specific requirements and clinical guidelines.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage determinations. Prior authorization requirements and appeals processes may change; verify current procedures with UnitedHealthcare and Virginia regulatory authorities.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.